This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Depending on the regulatory approval process or certification requirements by country, Kraton believes that BIAXAM could be used as a coating on personal protective equipment (PPE) and as a replaceable peel-and-stick film for a broad range of applications.
Kraton Corp. recently announced that it is seeking regulatory approval for BIAXAM, a sulfonated polymer technology with long-lasting self-disinfecting properties that has been demonstrated in studies to quickly inactivate up to 99.99% of SARS-CoV-2 (virus that causes COVID-19) and other microbes.
The severity of COVID-19 means that both consumer and industrial markets are now intensely interested in providing antimicrobial protection to employees and loved ones.
According to AkzoNobel, the extra functionality offered by the inclusion of antimicrobial technology means that building interiors can now be given increased protection against microbes such as bacteria and mold.
Increased demand for products that can improve hygiene has prompted AkzoNobel to accelerate the addition of antimicrobial properties to its Interpon D1000 and 2000 range of architectural powder coatings.
The coatings industry supports a number of commercial sectors that require critical product formulations to maintain the ongoing operations of their businesses and thereby support critical operations of their customers.
The Canadian Paint and Coatings Association (CPCA) recently shared that the paint and coatings industry continues to supply critical products in support of historic challenges brought on by the current pandemic.
The global market for medical device coatings is expected to grow to $6.3 billion by the end of 2014 and $9 billion in 2019, with a compound annual growth rate (CAGR) of 7.3% from 2014 to 2019, according to a recent report from BCC Research.